Hello V,
Totally agreed with you.
For medicinal value, worth a look, at IPO price.
I read the prospectus, p 66 & 97, directors have rewarded themselves
20m to 30m 'performance shares' that cost next to nothing.
Milestones is to get sp to 40c, then 60c, like today?
With few sh for sale, sp can go anywhere.
buyers beware, tears may flow.
opening price, page-16
-
- There are more pages in this discussion • 113 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
